USPTO serial 79432338
MRC-Q
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- HUDSON, TAMARA BREE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MRC-Q?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biopharmaceutical agents for the treatment of mitochondrial diseases, ophthalmic diseases, neurodegenerative diseases, cardiovascular diseases, ischemic injuries, muscle wasting diseases, metabolic disorders, cancer, age-related conditions, In Vitro Fertilization, and ex vivo use in cell culture and cell processing, namely, cell expansion, improvement of cell quality and function, and improvement of viability of cells; biopharmaceutical agents for cosmetic and health supplement use; pharmaceutical preparations for the treatment of mitochondrial diseases, ophthalmic diseases, neurodegenerative diseases, cardiovascular diseases, ischemic injuries, muscle wasting diseases, metabolic disorders, cancer, age-related conditions, In Vitro Fertilization, and ex vivo use in cell culture and cell processing, namely, cell expansion, improvement of cell quality and function, and improvement of viability of cells; pharmaceutical preparations for cosmetic and health supplement use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 2, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 11, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 31, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 26, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 6, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 6, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 11, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 10, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 11, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |